| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/27/2008 | US7378423 Antiproliferative, anticancer, antitumor agents; rheumatism; N-{3-[3-cyclopropyl-5-(2-fluoro-4-iodo-phenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydro-2H-pyrido[4,3-d]pyrimidin-1-yl]-phenyl}-acetamide; a p15, and/or a protein inducing action, and/or an MEK inhibitory action; side effect reduction |
| 05/27/2008 | US7378421 Chromenone derivatives |
| 05/27/2008 | US7378419 3-{[(5,5a,8a,9)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl]amino}-1-methyl-1H-pyrrole-2,5-dione; anticarcinogenic agent; inhibiting catalytic activity of topoisomerase II by stabilization of cleavable complex; better soluble and tolerated |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378411 Substituted thienopyrimidinones as a mitotic kinesin inhibitor |
| 05/27/2008 | US7378410 3,4,5-trihydroxy-2-methoxy-8,8-dimethyl-non-enoic acid ((3S,6S)-6-azido-2-oxo-azepan-3-yl)-amide; less toxicity, better selectivity in killing cancer cells, minimal effect on normal healthy cells |
| 05/27/2008 | US7378406 11 beta -(4-acetylphenyl)-17 beta-hydroxy-17-alpha-(1,1,2,2,2-pentafluoroethyl)-estra-4,9-dien-3-one or a derivative, especially for prophylaxis and treatmenet of breast cancer |
| 05/27/2008 | US7378404 For therapy of estrogen-deficiency-induced diseases and conditions |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378398 Administering a sulfoquinovosylacylglycerol; uterine cancer, breast cancer or pancreas adenocarcinoma cancer |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | US7378384 X-Y-Thr-Trp-Asn-Gln-Met-Asn-Leu wherein X represents Ser, Ala, Abu, Arg, Lys, Orn, Cit, Leu, Phe, or Asn, and Y represents Tyr or Met; cysteine residue is substituted with a defined amino acid residue; cancer vaccines |
| 05/27/2008 | US7378247 Tumor preferential polypeptide for use in the prevention treatment and diagnosis of cell proliferative disorders |
| 05/27/2008 | US7378237 Development of method for screening physiologically active pyrrole imidazole derivative |
| 05/27/2008 | US7378096 biodrugs comprising heat shock protein or glucose-regulated proteins complexed with immuogens including glycoproteins, her2/neu proteins or tuberculosis antigens, and carriers, used as anticarcinogenic agents |
| 05/27/2008 | US7378092 Immunogenic compositions for induction of anti-tumor immunity |
| 05/27/2008 | US7378091 Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| 05/27/2008 | US7378087 Method of enhancing an immune response |
| 05/27/2008 | US7378077 Hydrating a leukemia patient; parenterally administering a dose samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and melphalan, busulfan, and/or cyclophosphamiide; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/27/2008 | CA2384111C Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 05/22/2008 | WO2008061236A2 Sulfoximines as kinase inhibitors |
| 05/22/2008 | WO2008061201A1 Methods for treating renal tumors using 2,4-pyrimidinediamine drug and prodrug compounds |
| 05/22/2008 | WO2008061134A1 Derivatives of 18-amino substituted analogs of the geldamycin hydroquinon with cytotoxic activity for the treatment of cancer |
| 05/22/2008 | WO2008061108A2 Phthalazine derivatives |
| 05/22/2008 | WO2008061020A2 Methods of treating, diagnosing or detecting cancer |
| 05/22/2008 | WO2008061016A1 N-substituted piperidinyl 4 -arylsulfonamides as modulators of the secreted frizzled related protein- 1 |
| 05/22/2008 | WO2008061006A1 Substituted indan-2-yl, tetrahydronaphthalen-2-yl, or dihydr0-2h-chr0men-3-yl arylsulfonamides and methods of their use |
| 05/22/2008 | WO2008060932A2 Methods for improved engraftment following stem cell transplantation |
| 05/22/2008 | WO2008060907A2 Pyrrolo-pyridine kinase inhibitors |
| 05/22/2008 | WO2008060837A2 Methods and compositions for the treatment of cancer |
| 05/22/2008 | WO2008060771A2 Pyrazole compounds |
| 05/22/2008 | WO2008060645A2 Combinatorial therapy involving alpha5beta1 antagonists |
| 05/22/2008 | WO2008060569A1 Compounds and methods for inhibiting the interaction of bcl proteins with binding partners |
| 05/22/2008 | WO2008060491A2 Anti-vegf treatment for radiation -induced vasculopathy |
| 05/22/2008 | WO2008060372A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/22/2008 | WO2008060248A1 Indole sustituted pyrimidines and use thereof in the treatment of cancer |
| 05/22/2008 | WO2008059959A1 Nerve elongation promoter and elongation inhibitor |
| 05/22/2008 | WO2008059877A1 Aptamer against midkine and use thereof |
| 05/22/2008 | WO2008059819A1 Seaweed-derived immunostimulant and antiinflammatory agent |
| 05/22/2008 | WO2008059616A1 Antibody recognizing c-domain of midkine |
| 05/22/2008 | WO2008059491A1 Methods of treating cancer using sirna molecules directed against cd24 |
| 05/22/2008 | WO2008059368A2 Fused 2-amino pyrimidine compounds and their use for the treatment of cancer |
| 05/22/2008 | WO2008059238A1 Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer |
| 05/22/2008 | WO2008059141A1 Aminobenzocycloheptene derivatives, methods for preparing the same and uses thereof in therapy |
| 05/22/2008 | WO2008059126A1 Therapeutic use of at least one botulic neurotoxin in the treatment of pain induced by at least one antineoplastic agent |
| 05/22/2008 | WO2008059068A2 Carbonyl-substituted titanocenes |
| 05/22/2008 | WO2008059052A1 Improved methods of using phosphoantigen for the treatment of cancer |
| 05/22/2008 | WO2008058993A2 Use of alpha ketogluaric acid for the treatment of infection with h. pylori |
| 05/22/2008 | WO2008058728A1 Compositions and methods for immunotherapy |
| 05/22/2008 | WO2008058644A1 Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide |
| 05/22/2008 | WO2008058547A2 Alpha-lactalbumin composition |
| 05/22/2008 | WO2008058536A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |
| 05/22/2008 | WO2008058514A1 Preparations comprising boswellic acids for inhibiting the synthesis of prostaglandin e2 |
| 05/22/2008 | WO2008058451A2 Ultrasound microbubble mediated genes delivery system |
| 05/22/2008 | WO2008058449A1 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058448A1 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 05/22/2008 | WO2008058394A1 Polymorphisms predictive of anthracycline-induced cardiotoxicity |
| 05/22/2008 | WO2008058381A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058380A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058379A1 Cancerous disease modifying antibodies |
| 05/22/2008 | WO2008058366A1 Oil-in-water emulsions, methods of use thereof, methods of preparation thereof and kits thereof |
| 05/22/2008 | WO2008043087A3 Bicyclic nitrogen-containing heterocyclic compounds for use as stearoyl coa desaturase inhibitors |
| 05/22/2008 | WO2008042282A3 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 05/22/2008 | WO2008039751A3 2-methylene-(20s,25s)-19,27-dinor-(22e)-vitamin d analogs |
| 05/22/2008 | WO2008036981A9 Methods for treating mica-related disorders |
| 05/22/2008 | WO2008029282A3 Aqueous formulation comprising an antitumor agent |
| 05/22/2008 | WO2008021364A8 Triazole compounds that modulate hsp90 activity |
| 05/22/2008 | WO2008018783B1 Porphyrin activation by different spectrum electromagnetical waves-new malignant tumour treatment possibilities |
| 05/22/2008 | WO2008012413A3 Pyrimidinone derivatives and their use as a drug |
| 05/22/2008 | WO2008012365A3 Drug delivery system based on regioselectively amidated hyaluronic acid |
| 05/22/2008 | WO2008011726A8 Staged immune-response modulation in oncolytic therapy |
| 05/22/2008 | WO2008006974A3 Use of histamine h4 receptor ligands to protect haematopoietic progenitors against the haematological toxicity of chemotherapeutic agents |
| 05/22/2008 | WO2008005266A3 Method of using substituted piperidines that increase p53 activity |
| 05/22/2008 | WO2007127725A3 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 05/22/2008 | WO2007127010A9 Diarylthiohydantoin compounds |
| 05/22/2008 | WO2007124252A3 Combinations of therapeutic agents for treating cancer |
| 05/22/2008 | WO2007104557A3 Novel heterocyclic nf-kb inhibitors |
| 05/22/2008 | US20080119636 Methods and materials for cancer treatment |
| 05/22/2008 | US20080119572 Treatment for basal cell carcinoma |
| 05/22/2008 | US20080119568 Gastrointestinal Absorption Enhancer Mediated By Proton-Coupled Transporter and Its Preparing Method |
| 05/22/2008 | US20080119562 Methods of Inducing Terminal Differentiation |
| 05/22/2008 | US20080119559 Treatment or prevention of cancer and precancerous disorders |
| 05/22/2008 | US20080119558 Drug for Inhibiting Production of Matrix Metalloprotease-9 |
| 05/22/2008 | US20080119556 Geranly compounds |
| 05/22/2008 | US20080119546 Treatment of hyperproliferative conditions of body surfaces |
| 05/22/2008 | US20080119542 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 05/22/2008 | US20080119534 Benzimidazole Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119532 2-Methylamino-N-{2-(6-{1-methyl-2-(2-methylamino-propionylamino)-3-oxo-3-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-yl]-propoxy}-hexa-2,4-diynyloxy)-1-[2-(5-phenoxy-tetrazol-1-ylmethyl)-pyrrolidine-1-carbonyl]-propyl}-propionamide; mimetics of second mitochondria-derived activator of caspases |
| 05/22/2008 | US20080119530 Topically administrating an inhibitor of Erbb2 or HER2 receptor tyrosine kinase activity because of a novel connection between HER2 and a DNA damage checkpoint; reducing mutagenesis and apoptosis; antitumor, -carcinogenic, -proliferative agents and -inflammatory agents; sunburn; hyperplasia |
| 05/22/2008 | US20080119529 An epothilone derivative such as epothilone A,B,C or D with a bisphosphonate such as zoledronic acid, a platinum compound such as carboplatin or a vasculostatic compound such as vatalanib succinate; antitumor agents |
| 05/22/2008 | US20080119528 use of specific cyklolignans |
| 05/22/2008 | US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile |
| 05/22/2008 | US20080119514 6-(2,4-dinitrophenylazo)-2,5,7,8-tetramethyltridecyl))-1,2,3,4-tetrahydroquinoline; to treat cell proliferative diseases |
| 05/22/2008 | US20080119513 To treat osteoarthritis; matrix metalloproteinases-13 inhibitors |
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080119508 Multi-Route Administration Of Immune Response Modifier Compounds |
| 05/22/2008 | US20080119502 Vinca derivatives |
| 05/22/2008 | US20080119491 Amidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 05/22/2008 | US20080119479 Antiangiogenic and/or vascular permeability reducing effect; cancer involving a solid tumor or chronic myelogenous leukemia |